Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-026559
Filing Date
2010-03-22
Accepted
2010-03-19 21:11:37
Documents
3
Period of Report
2010-04-20
Effectiveness Date
2010-03-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A g22595def14a.htm DEF 14A 336069
2 GRAPHIC g22595g2259501.gif GRAPHIC 51877
3 GRAPHIC g22595g2259502.gif GRAPHIC 70759
  Complete submission text file 0000950123-10-026559.txt   506760
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33637 | Film No.: 10695381
SIC: 2834 Pharmaceutical Preparations